Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids

NCT01575873 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

795

Enrollment

INDUSTRY

Sponsor class

Conditions

Steroid-induced Osteopor, Glucocorticoid-induced Ostepor

Interventions

DRUG: Denosumab
DRUG: Placebo for risendronate
DRUG: Risendronate
DRUG: Placebo for denosumab

Sponsor

Amgen